In a radiomics study, Liang et al. reported that a T2-weighted image-based radiomics classifier was a significant predictor of Ki-67 status in patients with breast cancer, whereas contrast-enhanced image-based classifiers failed to discriminate in the validation dataset [153]. The gene discussed is MKI67; the disease is breast carcinoma.